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In the Americas, the Pan American Health
Organization supports strategies for the appropriate control
and elimination of vaccine-preventable diseases, especial-
ly if the strategies are designed to reduce health inequities,
strengthen the political commitment for immunization serv-
ices, and promote the culture of prevention. In September
2003, the 44th Directing Council of the Pan American
Health Organization adopted a goal to eliminate rubella and
congenital rubella syndrome by 2010. One of the main
objectives of this initiative is improving women’s health,
consistent with achieving the Millennium Development
Goals. An important component of rubella elimination is
conducting vaccination campaigns for men and women of
childbearing age to reduce rapidly the number of people
susceptible to rubella infection. From 1998 to 2002, the
English-speaking Caribbean, Chile, Costa Rica, Brazil, and
Honduras conducted mass rubella vaccination campaigns
aimed at adults. Vaccination coverage reached >95% in
each country with an exception of the Caribbean, where the
coverage was 80%.
T
he Pan American Health Organization (PAHO) sup-
ports strategies that encourage political commitment,
reduce inequities in health, and enhance the culture of pre-
vention (1). In that context, the initiative to eliminate
rubella and congenital rubella syndrome was adopted by
the directing council of PAHO in September 2003 (2).
Political commitment to expand coverage and reach chil-
dren and women who generally do not receive health serv-
ices is important to the success of this initiative. The work
of the national immunization program in the Americas is
not limited to children and includes reaching the adult pop-
ulation, especially women of childbearing age. 
The initial purpose of the Expanded Program on
Immunization (EPI) in the Americas, launched in 1977,
was to reduce illness and deaths from prevalent childhood
diseases that could be prevented with vaccination (3). EPI
accomplished this purpose by setting up and expanding
permanent services within the framework of primary
health care and by creating the necessary mechanisms for
effective, large-scale application of existing knowledge
and technology. 
Planning and developing EPI led to eradicating polio
and progress toward eliminating measles. The goal of
eliminating neonatal tetanus as a public health problem
was also met and sustained. Now, the region is challenged
with eliminating rubella and congenital rubella syndrome
by 2010. One of the main objectives is improving women’s
health, which is also one of the major Millennium
Development Goals in health (4). 
Eliminating polio from the Americas, with a reduction
in the number of reported cases from 6,653 in 1970 to 0 in
August 1991, is often sited as an example of effective col-
laboration among governments, nongovernmental organi-
zations, the private sector, and local communities (5).
Collaborators participated in implementing all aspects of
operations, including financing, training, surveillance,
vaccinating, and mobilizing mass media. The partners also
helped mobilize volunteers to access hard-to-reach popula-
tions for vaccination.
The experience and concrete products obtained during
the years of the polio elimination initiative benefited the
ministers of health by giving them the necessary confi-
dence and credibility for allocating adequate resources to
the current vaccination programs and embarking on new
initiatives. The countries now cover >80% of the expendi-
tures of routine vaccination programs, including the pur-
chase of vaccines. 
Building on the successful experience of Cuba and
English-speaking Caribbean countries in interrupting
endemic transmission of the measles virus, the ministers of
health adopted a resolution at the 24th Pan American
Sanitary Conference in 1994 to interrupt indigenous
measles transmission in the Americas by the year 2000.
From 1990 to 2002, the number of reported measles cases
declined by 99.2% in the Americas, with measles cases
plummeting from ≈250,000 cases in 1990 to 2,109 cases in
2002 (6). Since September 2001, no viruses of the D6
strain have been identified in the Americas, and the last
confirmed infection with d9 genotype was reported in
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As a consequence of administering at least two doses of
tetanus toxoid to women of childbearing age in high-risk
areas and ensuring that all cases were fully investigated,
the number of reported cases of neonatal tetanus declined.
In 2003, only 116 cases of neonatal tetanus were reported;
≈50% of them were in Haiti, the only remaining country in
the Americas where neonatal tetanus continues to be
endemic (7). 
Eliminating Rubella and Congenital Rubella
Syndrome from the Americas by 2010
Cuba was the first country to eliminate rubella and con-
genital rubella syndrome. The last reported case of con-
genital rubella syndrome in Cuba occurred in 1989 and the
last reported case of rubella in 1995. With measles elimi-
nation as a guide, similar strategies were proposed and
implemented for rubella and congenital rubella syndrome
elimination. This milestone was largely achieved by imple-
menting two mass vaccination campaigns from 1985 to
1986. Initially, the Cubans tried to reach women 18–30
years of age and, then, children 1–14 years of age (8). In
the rest of the region, the strengthening of measles surveil-
lance demonstrated that circulation of rubella virus was
widespread and that congenital rubella syndrome was an
important public health problem (Figure). In response to
the circulation of the rubella virus and the potential for the
emergence of rubella epidemics, the countries of the
Caribbean launched a subregional initiative in 1997 to
eliminate rubella and congenital rubella syndrome.
The adopted strategies included rapidly reducing the
susceptible population and implementing high-quality sur-
veillance. The specific strategies included using a rubella
vaccine in routine childhood vaccination programs, aiming
vaccination campaigns at men and women of childbearing
age, developing integrated measles and rubella surveil-
lance systems, implementing a congenital rubella syn-
drome surveillance system, and supporting improved lab-
oratory capacity for isolating rubella virus (9,10).
Beginning in 1999, other countries accelerated their
strategies for rubella control and the prevention of congen-
ital rubella syndrome. Chile (1999), Costa Rica (2001),
Brazil (2001–2002), Honduras (2002), and El Salvador and
Ecuador (2004) have conducted mass rubella vaccinations
among adults. They combined this strategy with the intro-
duction of the rubella vaccine into their national childhood
vaccination programs. This combination strategy is
designed to rapidly reduce rubella virus circulation, while
preventing a shift in the prevalence of the disease to suscep-
tible young adults, especially women of childbearing age.
The Caribbean, Costa Rica, Honduras, El Salvador, and
Ecuador vaccinated men as well as women, while Chile and
Brazil vaccinated only women of childbearing age. The
countries that only vaccinated women have reported cases
of rubella in 2004; the last congenital rubella syndrome
case in Chile was in 2001 and in Brazil in 2004 (11). 
By September 2004, a total of 43 countries and territo-
ries in the region had introduced vaccines containing the
rubella antigen (MR or MMR) in their national child vac-
cination program. The only remaining country, Haiti,
should do so in 2005.
The experiences of Cuba and the English-speaking
Caribbean countries strengthened the commitment for
rubella elimination in Chile, Costa Rica, Brazil, and
Honduras before the regional elimination initiative was
adopted by the directing council of PAHO. These experi-
ences showed that implementing strategies and recommen-
dations to eliminate rubella and congenital rubella syn-
drome was feasible. In addition, rubella elimination pro-
vided opportunities for strengthening the health system by
building partnerships and involving national and local
authorities (Table)
In the English-speaking Caribbean, the cost-benefit
ratio for vaccination was 13.3:1, and the cost-effectiveness
was U.S. $2,900 per prevented case of congenital rubella
syndrome. The comprehensive vaccination plan for adults
included strategies for safe injections and monitoring
adverse events during campaigns. In Chile, health promo-
tion was well-planned, and awareness among women
about their own health and their family’s increased. 
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Figure. Number of confirmed measles and
rubella cases, Americas, 1982–2003. Source:
IM/Pan American Health Organization.In Costa Rica, the decision to conduct the campaign
was based on epidemiologic information and cost benefit
analyses. The president of the republic declared the event
official by executive decree, which greatly facilitated
intersectoral coordination of public and private institu-
tions. The strategies to reach older populations in urban
and rural areas differed. In urban areas, vaccination teams
began with captive populations and ended with door-to-
door “mop-ups.” In rural areas, the campaign began in
more isolated places and moved towards city centers with
door-to-door “mop-ups” or micro-concentration. Enlisting
the participation of medical societies and professional
associations and the active involvement of health workers
were essential. Blood banks had to be involved so that the
nation’s blood supply was not threatened. The monitoring
of post-vaccination adverse events and immediate investi-
gation of events was considered a top priority. Extensive
follow-up studies of women who were vaccinated and not
known to be pregnant demonstrated that an increased risk
for adverse events did not exist.
In Brazil, social mobilization was the key to the success
of a vaccination campaign aimed at adults. Health profes-
sionals recognized as leaders and decision makers in the
country were called upon to explain the campaign and clar-
ify issues. A rapid response plan was put together in each
state to deal with crises or adverse events of vaccination,
and a telephone hotline was set up for the public. The most
common questions were where to go to be vaccinated
(36%), what to do if a pregnant woman had been vaccinat-
ed by mistake (14%), and other questions about adverse
events (10%). Health authorities used the rapid evaluation
tools to determine which groups of women had not been
vaccinated and designed effective methods to reach them.
In Honduras, adult men in marginal areas rarely seek
health services, so the campaign served to increase health
contacts.
In El Salvador, vaccination methods implemented dur-
ing the first 2 weeks were aimed at captive populations in
work and study centers and in high-transit areas or areas
with high populations. House-to-house vaccination was
continued after normal work hours to ensure that the adult
population was at home. In addition to promotion during
the campaign, the plan for social communication and
mobilization launched activities aimed at motivating blood
donors and avoiding blood shortages before the campaign. 
In Ecuador, a presidential decree urging public and pri-
vate sectors to participate was helpful. A total of 6,722
rapid coverage monitoring surveys were performed in
2,006 health units, and 75% of municipalities reported
coverage >95%. When coverage was not recorded, the sur-
veys helped to identify susceptible groups and implement
“mop-up” activities. The social communication showed
that the source of information from health units, TV, and
radio was most effective. School source information was
also helpful.
Surveillance
To accelerate the strategies to eliminate rubella and
congenital rubella syndrome, countries were challenged to
improve surveillance of congenital rubella syndrome,
while strengthening the already established integrated
measles and rubella surveillance system. Improving con-
genital rubella syndrome surveillance required that health
authorities more effectively identify and monitor women
of childbearing age who may have contracted rubella dur-
ing their pregnancy.
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Caribbean includes nearly 22,000 reporting sites. The net-
work encourages collaboration between the public and pri-
vate sectors. The network has contributed to the formation
of trained epidemiologists with experience in surveillance,
disease control, and operations research to respond to new,
emerging, and reemerging infectious diseases, such as
cholera, influenza, and yellow fever (19). The surveillance
work has also contributed to women having more frequent
contact with prenatal services.
Implementing congenital rubella syndrome surveil-
lance is particularly important during the initial phase of
elimination to monitor effectiveness of congenital rubella
syndrome prevention. Moreover, all countries are setting
up consultation teams in hospitals for congenital infections
with the active participation of neonatologists. Well-baby
check-ups are used to look for congenital malformations.
As a by-product, national registries for identifying all con-
genital malformations and ensuring their follow-up are
being strengthened. 
Discussion
Strengthening health services by implementing high-
quality congenital rubella syndrome surveillance, periodic
well-baby check-ups, or setting up areas for consultations
for congenital infections is essential for high-quality, com-
prehensive perinatal care. The use of these perinatal infor-
mation systems improves the monitoring of children with
congenital malformations and provides them with
increased contact with rehabilitation and special education
services. The by-product of such efforts is providing
patients with better, more specialized care and referrals.
Empowering women with the knowledge of prevention
is a key strategy for improving the quality of health care
for women (20). The communication and social mobiliza-
tion strategies of the rubella and congenital rubella syn-
drome elimination initiative are designed to enable women
to make their own choices, exercise their rights, and
demand improved health care. 
Regional perinatal information systems, such as the
Latin-American Center for Perinatology and Human
Development and the Congenital Malformation Latin-
American Collaborative Study, help to improve surveil-
lance and services for newborns (21). These systems also
provide valuable information on maternal deaths and are
important in investigating all maternal deaths. 
The rubella elimination initiative offers an opportunity
to put adults in more frequent contact with the health serv-
ices. In some communities, adult men also make key deci-
sions affecting care-seeking for women and their new-
borns. Thus, men must be aware of women’s needs, risks,
and warning signs. Promoting men’s roles as partners and
fathers is essential for enlisting their participation and sup-
port, a message that is always conveyed during adult vac-
cination campaigns (22). In some communities, mothers
may more easily gain access to specific health services if
they have the full support of other family members, espe-
cially their husband. 
Amajor challenge in women’s and perinatal health care
is ensuring universal access, which means bring healthcare
services high-risk communities where poor and under-
served groups live. Because the vaccination campaign is
aimed at 100% of the population, inequities based on sex,
ethnicity, social class, race, and geographic distribution are
reduced. This experience also greatly contributes to the
reduction of inequities of maternal health outcomes (23).
To improve the health of all persons, scientists, health
providers, administrators, business, media, and religious
leaders, and all other sectors of society must be enlisted.
The most fundamental challenges faced by the rubella
elimination initiative are the mobilization and coordination
of all sectors in a joint cause. Promoting women’s health
care and safe motherhood should be well grounded in a
multisector approach that requires carefully building and
maintaining partnerships.
Immunization services aimed at protecting children
have played a decisive role in improving childhood health
in the Americas. The foundation for expanding vaccination
to other age groups should generate opportunities for
strengthening health services for adults. Countries in the
Americas are working hard to extend the benefits in the
fields of social mobilization, community participation,
staff education, epidemiologic surveillance, and program
management. Countries are also committed to ensuring
that the rubella elimination initiative plays a major role in
improving women’s health care. 
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